Today, Tibotec, a subsidiary of Johnson & Johnson, announced it has signed voluntary licensing agreements with several Indian and South African generic companies to allow generic competition on a new HIV-AIDS treatment, the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278) (rilpivirine hydrochloride), to certain developing countries. Continue Reading
On November 19, 2010, Knowledge Ecology International, Medecins Sans Frontieres/Doctors without Borders, Oxfam America and Public Citizen answered a Request for Comments from the US Department of Commerce on a proposal to “Incentivize Humanitarian Technologies and Licensing Through the Intellectual Property System”.
Today, Wednesday November 10 2010, during the 3rd day of the WIPO SCCR21, the Group B presented a proposal for a Work Program on copyright exceptions and limitations for the WIPO SCCR. Group B is the negotiation group that groups developed countries like US, EU, Switzerland and others.
The proposal is available here
In a October 7, 2010 letter, Professor Michel Kazatchkine, the Executive Director of the Global Fund to fight AIDS, Tuberculosis and Malaria, has written to Dr. Jorge Bermudez, the UNITAID Executive Director, to discuss the Medicines Patent Pool.
Kazatchkine congratulates UNITAID for the announcement that an agreement had been reached between U.S. National Institute for Health and the Medicines Patent Pool for the voluntary license of the NIH patents rights on an HIV-AID drug, Darunavir.
On November 2, 2010, U.S. Senator Bernard Sanders (VT-I) sent a letter to Margaret Hamburg, the FDA Commissioner, urging the agency to review the ethical implications of the 12 years of marketing exclusivity created by the Biologics Price Competition and Innovation Act of 2009 (BPCI Act).
Notes on the October 7, 2010 USTR NGO briefing on ACTA
By Judit Rius Sanjuan & Anne Mira Guha
Today, USTR held a nearly 2-hour public briefing on the new version of the ACTA text. USTR representatives present included Stan McCoy, Kira Alvarez, and Rachel Bae. Stan and Kira did most of the talking at the meeting.
Esta es la version de las 3.30 pm del 24 de junio del 2010 del proyecto de conclusiones de la OMPI SCCR 20 en espanol. El documento fue distribuido durante el dia de hoy por el secretariado de la OMPI y esta siendo discutido. Este texto va a ser negociado esta tarde.
Organización Mundial de la Propiedad Intelectual
Comité de Derecho de Autor y Derechos Conexos (SCCR)
Ginebra, 21 a 24 de junio de 2010
Proyecto de conclusiones
PROTECCIÓN DE LOS ORGANISMOS DE RADIODIFUSIÓN
In briefings about the WIPO proposal for a treaty for persons who are blind or have other disabilities, the U.S. government has sent mixed signals regarding the legality of exporting of accessible works created under exceptions in U.S. law. In some informal briefings and conversations, the U.S. government has said such exports are allowed under U.S. law. At other times, they say they are not.
KEI has obtained a June 12, 2008 memo from the U.S. Copyright Office, written by Neil Conley to David Carson, that analyzes the possible extraterritorial effects of the Chafee Amendment.
On June 7, 2010 medicine access advocacy groups joined together in asking that George Washington University (GWU) put a stop to its industry-sponsored intellectual property (IP) summits and to take an academic, evidenced-based approach to conferences it conducts in India. Continue Reading